SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-19-040169
Filing Date
2019-02-14
Accepted
2019-02-14 13:47:03
Documents
1
Group Members
AMIN NATHOOANSON ADVISORS INC.ANSON MANAGEMENT GP LLCBRUCE R. WINSONMOEZ KASSAM

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d683579dsc13ga.htm SC 13G/A 123661
  Complete submission text file 0001193125-19-040169.txt   125597
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Subject) CIK: 0001292519 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-85686 | Film No.: 19604233
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address 5950 BERKSHIRE LANE SUITE 210 DALLAS TX 75225
Business Address 5950 BERKSHIRE LANE SUITE 210 DALLAS TX 75225 214.866.0202
Anson Funds Management LP (Filed by) CIK: 0001491072 (see all company filings)

IRS No.: 300134498 | State of Incorp.: TX | Fiscal Year End: 1231
Type: SC 13G/A